Tag: Eli Lilly and Co

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

U.S. executives, from Apple to Eli Lilly, revamp their push into the world’s second-largest economy at the China Development Forum

Danone to buy protein shake maker Huel as health nutrition craze drives demand shift

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says